The non-NF1 comparison group was frequency-matched to the NF1 group at a 10 1 ratio by one year age group on 1/1/2006 or first enrollment if born after 1/1/2006 and enrollment length in months.
#The Odds ratio shown is for 10 years increases (i.e., the tenth power of Odds ratio per one year of age).
Dry cough at night and cough without infection were associated with slightly increased odds ratios at one year but the associations were significant only in boys.
We computed the hazard ratio (and associated 95% confidence intervals) as a measure of mortality ratio, separately, for one year and greater than one year post-diagnosis.
However, there was a lower number of reattempts in intervention group among suicide attempters repeaters (incidence risk ratio 0.55 at one year, and 0.49 at two years).
However, among SA repeaters there was a lower number of reattempts in contact group (incidence risk ratio 0.55 at one year, and 0.49 at two years).
3,095 individuals were randomized in a 2 1 ratio into a one year trial aimed to assess the safety and efficacy of Cycloset™ compared to placebo among individuals receiving a variety of treatments for type 2 diabetes.
Odds ratio are per one year increase in age, one point increase in Acute Physiology and Chronic Health Evaluation (APACHE II) score, the presence versus absence of chronic liver disease, one log increase in cell-free hemoglobin, and one log increase in hemopexin level.
In contrast, retirement was associated with a substantial decrease in the prevalence of both mental fatigue (odds ratio for fatigue one year after versus one year before retirement 0.19, 95% confidence interval 0.18 to 0.21) and physical fatigue (0.27, 0.26 to 0.30).
In adjusted analysis, increasing age of the child was associated with increasing odds of infection (adjusted odds ratio (AOR) for one year increase in age: 1.43; 95% CI: 1.13-1.91; p = 0.002); children of Colored ethnicity (compared to children of Xhosa ethnicity) were also more likely to be infected (AOR: 2.51; 95% CI: 1.22-5.17; p = 0.01).
